TX HB1987

Repeals Chapter 170A of the Health and Safety Code and Chapter 6-1/2, Title 71 of the Revised Statutes, which contain laws prohibiting abortion in Texas

Narrows abortion complication reporting requirements to apply only to physicians who perform or treat complications at abortion facilities, rather than all healthcare providers who treat such complications

Requires abortion-inducing drugs to be provided only by physicians following FDA-approved protocols as outlined in the drug's final printed label

Allows abortion-inducing drugs to be provided in dosage amounts prescribed by the American College of Obstetricians and Gynecologists Practice Bulletin guidelines as they existed on January 1, 2013

Requires physicians to schedule a follow-up visit within 14 days after administration of abortion-inducing drugs to confirm pregnancy termination and assess blood loss